Status:
UNKNOWN
Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter Study
Lead Sponsor:
HaEmek Medical Center, Israel
Conditions:
Sickle Cell Anemia
Sickle Cell β+ or β0 Thalassemia
Eligibility:
All Genders
1-40 years
Brief Summary
The purpose of this study is to take advance of the presence of two different cohorts of SCA patients in one country, the first group included SCA patients from Bedouin Arab origin that lives in Israe...
Detailed Description
Group 1 - Emek group - (EMC): 100 patients will be included in the study, including Homozygous SCA patients and Sickle Cell β Thalassemia Patients (β0 and β+ patients will be included). Group 2 - Dan...
Eligibility Criteria
Inclusion
- All patients followed up in the centers that participate in the study.
- Pregnancy will not be considered as exclusion criteria.
Exclusion
- Patients with SC and SD disease will not be included.
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01905787
Start Date
January 1 2012
End Date
December 31 2020
Last Update
October 31 2019
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Michigan, Detroit Medical Center - Wayne State University
Detroit, Michigan, United States
2
Pediatric Hematology Unit HaEmek Medical Center
Afula, Israel, 18101
3
Pediatric Hematology Unit - Schneider Children's Hospital - Beilinson Medical Center
Petah Tikva, Israel
4
Pediatric Hematology Unit - Dana Children's Hospital - Ichilov Medical Center
Tel Aviv, Israel